Reduced expression of the chromatin remodeling gene ARID1A enhances gastric cancer cell migration and invasion via downregulation of E-cadherin transcription

Carcinogenesis

Volumn 35, Issue 4, 2014, Pages 867-876

  Yan, Hai Bo ^a   Wang, Xue Fei ^a   Zhang, Qian ^a   Tang, Zhao Qing ^a   Jiang, Ying Hua ^a   Fan, Hui Zhi ^a   Sun, Yi Hong ^a   Yang, Peng Yuan ^a   Liu, Feng ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOBLASTOMA BINDING PROTEIN 2; UVOMORULIN;

ARTICLE; CANCER CELL; CANCER INFILTRATION; CANCER PROGNOSIS; CELL INVASION; CELL MEMBRANE; CELL MIGRATION; CELL STRUCTURE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; STOMACH CANCER; UPREGULATION;

CADHERINS; CELL LINE, TUMOR; CHROMATIN ASSEMBLY AND DISASSEMBLY; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; GENE SILENCING; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NUCLEAR PROTEINS; PROGNOSIS; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 84898615046     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt398     Document Type: Article

References (48)

1. Roberts, C.W. et al. (2004) The SWI/SNF complex-chromatin and cancer. Nat. Rev. Cancer, 4, 133-142.
2. Wilson, B.G. et al. (2011) SWI/SNF nucleosome remodellers and cancer. Nat. Rev. Cancer, 11, 481-492.
3. Jones, S. et al. (2012) Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types. Hum. Mutat., 33, 100-103.
4. Wu, J.N. et al. (2013) ARID1A mutations in cancer: another epigenetic tumor suppressor? Cancer Discov., 3, 35-43.
5. Wiegand, K.C. et al. (2010) ARID1A mutations in endometriosis-associated ovarian carcinomas. N. Engl. J. Med., 363, 1532-1543.
6. Jones, S. et al. (2010) Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science, 330, 228-231.
7. Giulino-Roth, L. et al. (2012) Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes. Blood, 120, 5181-5184.
8. Guichard, C. et al. (2012) Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat. Genet., 44, 694-698.
9. Fujimoto, A. et al. (2012) Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat. Genet., 44, 760-764.
10. Huang, J. et al. (2012) Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma. Nat. Genet., 44, 1117-1121.
11. Sausen, M. et al. (2013) Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma. Nat. Genet., 45, 12-17.
12. Imielinski, M. et al. (2012) Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell, 150, 1107-1120.
13. Le Gallo, M. et al. (2012) Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes. Nat. Genet., 44, 1310-1315.
14. Varela, I. et al. (2011) Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature, 469, 539-542.
15. Gui, Y. et al. (2011) Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat. Genet., 43, 875-878.
16. Zhang, J. et al. (2013) Genetic heterogeneity of diffuse large B-cell lymphoma. Proc. Natl. Acad. Sci. USA, 110, 1398-1403.
17. Streppel, M.M. et al. (2013) Next-generation sequencing of endoscopic biopsies identifies ARID1A as a tumor-suppressor gene in Barrett's esophagus. Oncogene. doi:10.1038/onc.2012.586.
18. Cancer Genome Atlas, N. (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487, 330-337.
19. Biankin, A.V. et al. (2012) Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature, 491, 399-405.
20. Wang, K. et al. (2011) Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nat. Genet., 43, 1219-1223.
21. Zang, Z.J. et al. (2012) Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes. Nat. Genet., 44, 570-574.
22. Guan, B. et al. (2011) ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers. Cancer Res., 71, 6718-6727.
23. Wang, D.D. et al. (2012) Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer. PLoS One, 7, e40364.
24. Mamo, A. et al. (2012) An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer. Oncogene, 31, 2090-2100.
25. Van Rechem, C. et al. (2009) HIC1 interacts with a specific subunit of SWI/SNF complexes, ARID1A/BAF250A. Biochem. Biophys. Res. Commun., 385, 586-590.
26. Nagl, N.G. Jr et al. (2006) The c-myc gene is a direct target of mammalian SWI/SNF-related complexes during differentiation-associated cell cycle arrest. Cancer Res., 66, 1289-1293.
27. Nagl, N.G. Jr et al. (2007) Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control. EMBO J., 26, 752-763.
28. Love, C. et al. (2012) The genetic landscape of mutations in Burkitt lymphoma. Nat. Genet., 44, 1321-1325.
29. Zeng, Y. et al. (2013) ARID1A is a tumour suppressor and inhibits glioma cell proliferation via the PI3K pathway. Head Neck Oncol., 5, 6.
30. Liang, H. et al. (2012) Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer. Genome Res., 22, 2120-2129.
31. Sastry, L. et al. (2002) Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods. Gene Ther., 9, 1155-1162.
32. Cascio, S. et al. (2011) MUC1 protein expression in tumor cells regulates transcription of proinflammatory cytokines by forming a complex with nuclear factor-κB p65 and binding to cytokine promoters: importance of extracellular domain. J. Biol. Chem., 286, 42248-42256.
33. Wang, X. et al. (2013) Clinical and prognostic implications of ß1, 6-N-acetylglucosaminyltransferase V in patients with gastric cancer. Cancer Sci., 104, 185-193.
34. He, H. et al. (2012) Snail is an independent prognostic predictor for progression and patient survival of gastric cancer. Cancer Sci., 103, 1296-1303.
35. Abe, H. et al. (2012) ARID1A expression loss in gastric cancer: pathwaydependent roles with and without Epstein-Barr virus infection and microsatellite instability. Virchows Arch., 461, 367-377.
36. Jang, B.G. et al. (2011) Molecular pathology of gastric carcinoma. Pathobiology, 78, 302-310.
37. Zhao, C. et al. (2012) Promoter methylation of tumor-related genes in gastric carcinogenesis. Histol. Histopathol., 27, 1271-1282.
38. Chandler, R.L. et al. (2013) ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF. Mol. Cell. Biol., 33, 265-280.
39. Kim, K. et al. (2002) Direct evidence for a role of beta-catenin/LEF-1 signaling pathway in induction of EMT. Cell Biol. Int., 26, 463-476.
40. Müller, T. et al. (2002) Regulation of epithelial cell migration and tumor formation by beta-catenin signaling. Exp. Cell Res., 280, 119-133.
41. Zhang, X. et al. (2012) Frequent low expression of chromatin remodeling gene ARID1A in breast cancer and its clinical significance. Cancer Epidemiol., 36, 288-293.
42. Zhang, X. et al. (2013) Promoter hypermethylation of ARID1A gene is responsible for its low mRNA expression in many invasive breast cancers. PLoS One, 8, e53931.
43. Bosse, T. et al. (2013) Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer. Mod Pathol., 26, 1525-1535.
44. Skubitz, A.P. (2002) Adhesion molecules. Cancer Treat. Res., 107, 305-329.
45. Xing, X. et al. (2013) The prognostic value of E-cadherin in gastric cancer: a meta-analysis. Int. J. Cancer, 132, 2589-2596.
46. Zhang, K.L. et al. (2008) Increased frequency of CpG island methylator phenotype and CDH1 methylation in a gastric cancer high-risk region of china. Transl. Oncol., 1, 28-35.
47. Wijnhoven, B.P. et al. (2000) E-cadherin-catenin cell-cell adhesion complex and human cancer. Br. J. Surg., 87, 992-1005.
48. Suzuki, H. et al. (2008) Nuclear beta-catenin expression at the invasive front and in the vessels predicts liver metastasis in colorectal carcinoma. Anticancer Res., 28, 1821-1830.